Prospective evaluation of the efficacy of inhaled steroids administered via the AeroDawg spacing chamber in management of dogs with chronic cough
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16673 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2023. Written by Jennifer C Chan and 1 co-authors. Institution: William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, California, 95616, …. Major MEDLINE topics: Asthma, Dog Diseases. Cited 6 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Bailey Wrigley Fund, Trudell Medical International, University of California, Davis Center for Companion Animal Health.
Abstract (original language)
Background
Glucocorticoids are frequently required for management of cough because of inflammatory airway disease (IAD) and airway collapse (AWC). Objectives/Hypothesis To determine the efficacy and feasibility of inhaled administration of corticosteroids in controlling cough in dogs with noninfectious airway disease. Animals Thirty-six client-owned dogs.
Methods
Dogs were prospectively recruited for this placebo-controlled cross-over study. Inflammatory airway disease was diagnosed through bronchoalveolar lavage cytology. Airway collapse was diagnosed through bronchoscopy, or if dogs were unsuitable anesthetic candidates, by crackles on auscultation, radiographic changes in airway diameter, or fluoroscopy. Dogs were randomly assigned to receive placebo or fluticasone propionate for the first 2 weeks of the trial then crossed over to fluticasone. A quality of life (QOL) survey (best score 0, worst score 85) was completed at 0 and 6 weeks. A visual-analog cough survey was submitted at 0, 2, 4, and 6 weeks to assess cough, feasibility, and adverse effects of treatment.
Results
For 32 dogs, QOL score at study end (mean 11.3 ± 9.7) was significantly lower (P < .0001) compared to entry (mean 28.1 ± 14.1), with a median change of 69% in QOL score, indicating improved quality of life. Cough frequency, duration, and severity were significantly (P < .0001) decreased at study end. Feasibility of aerosolized delivery improved with continued use (P = .05) with only 1 dog unable to accept inhaled medication. Conclusion and Clinical Importance This study supports the utility of fluticasone propionate by inhalation in management of cough in dogs with IAD and AWC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, California, 95616, USA.
- Department of Medicine & Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, 95616, USA.
ORCID profiles: Jennifer C Chan, Lynelle R Johnson
Funding
- Bailey Wrigley Fund
- Trudell Medical International
- University of California, Davis Center for Companion Animal Health
- University of California
Cite
APA
Chan, J. C., & Johnson, L. R. (2023). Prospective evaluation of the efficacy of inhaled steroids administered via the AeroDawg spacing chamber in management of dogs with chronic cough. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16673
Vancouver
Chan JC, Johnson LR. Prospective evaluation of the efficacy of inhaled steroids administered via the AeroDawg spacing chamber in management of dogs with chronic cough. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16673
BibTeX
@article{Chan2023,
author = {Chan, Jennifer C and Johnson, Lynelle R},
title = {Prospective evaluation of the efficacy of inhaled steroids administered via the AeroDawg spacing chamber in management of dogs with chronic cough},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16673}
}
EUVIMED